Hair Loss in a Young Man

Clinical Scenario

Georges Remy, 29, calls to discuss hair loss. He has been losing hair in a typical male pattern (frontal recession and vertex thinning) for approximately 2 years. He has tried minoxidil 5% topically for 6 months with minimal improvement. He has researched finasteride online and is requesting a prescription. He has no significant medical history. Georges works in a client-facing role and the hair loss is significantly affecting his confidence and self-esteem.

What This Case Tests

Confirming the diagnosis of androgenetic alopecia and excluding other causes; counselling on finasteride including the sexual side effect profile (erectile dysfunction, reduced libido); discussing the evidence for finasteride versus other options; addressing the psychological impact of hair loss in a young man; shared decision-making around a medication with significant potential side effects.

Common Mistakes Trainees Make

The three most common mistakes are: prescribing finasteride without adequate side effect counselling (sexual dysfunction occurs in 1-2% and can occasionally persist after stopping — patients must be informed), dismissing the psychological impact of hair loss as vanity (it significantly affects quality of life and mental health in young men), and not excluding other causes of hair loss (thyroid disease, iron deficiency, alopecia areata) before confirming male pattern baldness.

The Consultation Challenge

Georges has done his research, tried first-line treatment (minoxidil), and wants finasteride. He is a well-informed patient with a specific request. The consultation tests whether you can prescribe responsibly with adequate informed consent, not whether you can talk him out of it.

Start by confirming the diagnosis. Male pattern baldness (androgenetic alopecia) has a characteristic pattern: frontal hairline recession and vertex thinning with preserved hair at the sides and back. Ask about the pattern, timeline, family history (strongly genetic), and exclude red flags: patchy loss (alopecia areata), diffuse thinning (thyroid, iron deficiency), scalp inflammation or scarring (scarring alopecia), and associated symptoms (fatigue, weight change suggesting thyroid). If the pattern is classic and there are no red flags, the diagnosis is clinical.

Acknowledge the psychological impact. Hair loss in a 29-year-old man in a client-facing role is not trivial. It affects confidence, social interactions, and self-perception. Validate this: "I can see this is having a real impact on your confidence, and I take that seriously."

Review what he has tried. Minoxidil 5% for 6 months with minimal improvement is a reasonable first-line trial. It works for approximately 40% of men and results take 4-6 months to appear. If he has been compliant and seen no benefit, stepping up to finasteride is clinically appropriate.

Counsel on finasteride thoroughly. Finasteride 1mg daily blocks the conversion of testosterone to DHT (the hormone driving hair loss). It is effective in 80-90% of men, typically halting loss and often achieving regrowth. However, the side effect profile requires explicit discussion: decreased libido (1-2%), erectile dysfunction (1-2%), reduced ejaculate volume, and — rarely — persistent sexual side effects after discontinuation (post-finasteride syndrome, controversial but reported). Depression and breast tenderness are also reported rarely.

Finasteride is not NHS-funded for hair loss — it would be a private prescription. Ensure Georges understands this.

If he understands the risks and wants to proceed, prescribe with a review at 3-6 months to assess response and side effects.

Time check: Spend the first 3 minutes confirming the diagnosis and excluding other causes. Address the psychological impact by minute 5. Review previous treatment and explain finasteride between minutes 6-9. Complete the informed consent discussion by minute 11. Use the final minute for the prescription and follow-up plan.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you confirm androgenetic alopecia through history (pattern, timeline, family history) and exclude differentials (thyroid disease, iron deficiency, alopecia areata, scarring alopecia). They look for a review of the minoxidil trial (dose, duration, compliance, response) and screening for contraindications to finasteride (liver disease, planned conception with a partner — finasteride is teratogenic).

Clinical Management and Medical Complexity: Examiners expect comprehensive finasteride counselling including mechanism of action, expected timeline for effect (3-6 months), sexual side effects with specific percentages, the persistence controversy, and the fact that benefits reverse on stopping. They look for awareness that this is a private prescription (not NHS-funded for hair loss) and a clear follow-up plan. A trainee who prescribes without mentioning sexual side effects will score very poorly.

Relating to Others: Examiners assess whether you take the psychological impact seriously rather than treating this as a cosmetic concern, validate Georges's distress about his appearance, and conduct the informed consent discussion as a genuine partnership. The patient should feel that his concern is respected and that the decision is truly his.

Example Opening

Strong opening: "Hello Georges, I can see you want to talk about your hair loss. I know this can be really frustrating, especially when it affects your confidence at work. Can you tell me about what's been happening and what you've tried so far?"

When counselling on finasteride: "Finasteride is effective — it works for about 80-90% of men and often produces regrowth, not just stopping the loss. But I need to be upfront about the side effects. About 1-2 in every 100 men experience sexual side effects — reduced libido or difficulty with erections. For most men, these reverse when they stop the medication, but there are rare reports of them persisting. I want you to have all the information before you decide."

Avoid: "It's just cosmetic — lots of men go bald." (Dismissive of a legitimate quality of life concern).

How This Appears in the SCA

This case tests informed consent for a medication with significant potential side effects. The examiner assesses whether you counsel on sexual side effects clearly and completely, acknowledge the psychological impact of hair loss, and support shared decision-making. Prescribing without adequate counselling or dismissing the request as cosmetic both score poorly.

Key Statistic

Male pattern baldness affects approximately 50% of men by age 50 and 80% by age 70. Finasteride 1mg daily prevents further hair loss in approximately 80-90% of men and produces visible regrowth in approximately 65%. Sexual side effects occur in 1-2% and are usually reversible on stopping.

Relevant Guidelines

• NICE CKS: Alopecia — androgenetic
• British Association of Dermatologists (BAD) patient information on male pattern hair loss
• BNF guidance on finasteride for hair loss.

Frequently Asked Questions

Do I need to exclude other causes before diagnosing male pattern baldness?

Yes — briefly. While the pattern is usually clinically obvious, examiners expect you to consider differentials: alopecia areata (patchy, well-demarcated loss), thyroid disease (diffuse thinning with other symptoms), iron deficiency (diffuse thinning, fatigue), and scarring alopecia (scalp inflammation, permanent loss). If the pattern is classic androgenetic alopecia with no red flags, blood tests are not routinely needed. If there is any atypical feature, check TFTs, ferritin, and FBC.

What sexual side effects should I counsel about with finasteride?

Decreased libido (1-2%), erectile dysfunction (1-2%), reduced ejaculate volume, and rarely gynaecomastia. Most side effects resolve on discontinuation. The controversial area is post-finasteride syndrome — persistent sexual, neurological, and psychological symptoms after stopping — which is reported but not universally accepted as a distinct entity. Present this honestly: "Most men have no problems, and for those who do, stopping the medication usually resolves it. There are rare reports of side effects persisting, and I want you to be aware of that possibility."

Is finasteride available on the NHS for hair loss?

No — finasteride for male pattern hair loss is not NHS-funded. It requires a private prescription. The cost is approximately 30-50p per day from reputable online pharmacies. Ensure the patient knows this before prescribing. Finasteride IS NHS-funded for BPH (benign prostatic hyperplasia) at a higher dose (5mg), but prescribing the 5mg dose and splitting tablets for hair loss is not recommended.

How do I address the psychological impact of hair loss in a young man?

Take it seriously. Hair loss in young men is associated with reduced self-esteem, social anxiety, depression, and avoidance of social situations. Validate the impact: "I can see this is affecting your confidence, and that's completely understandable." If the psychological impact seems disproportionate or suggests clinical depression, screen for mood disorder and consider additional support. Treating hair loss as trivial or cosmetic is dismissive and scores poorly.

What alternatives to finasteride should I mention?

Minoxidil 5% topical (already tried — can continue alongside finasteride for additive effect), low-level laser therapy (some evidence, expensive), hair transplant surgery (effective but costly, typically considered after stabilising loss with medication), and scalp micropigmentation (cosmetic tattooing). Dutasteride is used off-licence for hair loss with stronger DHT inhibition but more side effects. For completeness, mention that acceptance and confidence-building are also valid approaches.